Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,207 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04740424RecruitingPhase 1
First study of a new drug for advanced solid cancers
This Phase 1 trial tests a brand-new treatment (given at increasing doses) for people with advanced, unresectable, or metastatic solid tumors. It mainly looks at safety and how the drug behaves in the body, and it may help if standard treatments didn’t work or aren’t suitable.
Waratah, New South WalesAges 18 years+ - NCT05339438Recruiting
Brain scan mapping before epilepsy surgery
This study uses a special MRI scan to map parts of the front-temporal brain in people with drug-resistant epilepsy who may need surgery. The goal is to better plan surgery by showing which brain areas are involved.
NancyAges 18 years+ - NCT06129890Recruiting
Brain stimulation for nerve pain and depression
This trial tests whether a noninvasive brain stimulation technique (rTMS) can help people with long-term nerve pain who also have depression. It aims to see if this treatment can reduce pain and improve mood.
Saint-EtienneAges 18–85 - NCT06332573Recruiting
Onco-sexology support for newly diagnosed cancer patients
This trial tests whether talking with a specialist about sexual well-being can improve your quality of life after a new cancer diagnosis. It's for anyone aged 18 or older, including those receiving palliative care.
MarseilleAges 18 years+ - NCT06410131RecruitingPhase 1
Safety study of FTL008.16 for advanced solid tumors
This trial tests an investigational drug called FTL008.16 for people with advanced solid tumors that may carry a protein called 5T4. The main goal is to see if the drug is safe and tolerable.
Beijing, Beijing MunicipalityAges 18–75 - NCT06814054Recruiting
Predicting low blood pressure after anesthesia in older patients
This study uses ultrasound measurements of the carotid artery and vena cava to predict if older patients might experience low blood pressure after going under general anesthesia for elective surgery. If successful, it could help doctors take preventive steps.
Tanta, El GharbyiaAges 65 years+ - NCT06148883Recruiting
Managing new heart block after TAVI
This study looks at people who develop a new heart block (left bundle branch block) after having a minimally invasive aortic valve replacement. Researchers want to find the best way to manage this condition to prevent future heart problems.
MarseilleAges 18 years+ - NCT06216873Recruiting
Studying movement and survival in multiple trauma patients
This trial collects information from people with multiple injuries (multiple trauma) to see how their ability to move affects their chances of survival. It may help doctors understand which treatments work best for recovery.
Chiayi CityAges Any age - NCT06451744Recruiting
Study of biomarkers in lichen planus
This study looks at people with lichen planus (a rash that can affect skin, mouth, or genitals) to find markers in cells and blood that may help understand the disease. If you have a new diagnosis or a flare-up, and you are not on strong immune-suppressing medicine, you may be able to join.
BesançonAges 18 years+ - NCT06726239Recruiting
Relaxation exercises before getting up after heart bypass
This study tests whether doing gentle relaxation exercises before getting out of bed can help reduce pain, anxiety, and stress after heart bypass surgery. It may make recovery more comfortable.
Istanbul, IstanbulAges 35–65 - NCT06756139Recruiting
Mobile app therapy for stubborn stomach upset
This study tests if a mobile app teaching cognitive behavioral therapy (a way to change thinking patterns) can help people with stubborn stomach pain or discomfort. It might benefit those whose symptoms haven't improved with usual medicines.
Haikou, HainanAges 18–80 - NCT06874283Recruiting
Eye problems from cancer treatment registry
This study collects information and eye health data from people who have had cancer treatment, including stem cell transplants. It helps doctors understand how cancer therapies affect the eyes over time.
Baltimore, MarylandAges 18 years+ - NCT06868992Recruiting
Study of MASH and cell changes in weight-loss surgery
This study looks at a possible link between MASH (liver inflammation with fat buildup) and tiny cell structures that help liver cells work. Researchers want to understand this better in people having weight-loss surgery, where a small liver sample will be taken.
Lyon, FranceAges 18–99 - NCT06869031Recruiting
Helping rural patients manage high blood pressure with their doctor
This study tests a new way to help people with high blood pressure in rural areas manage their condition better. It focuses on improving how you and your doctor work together to keep your blood pressure under control.
Chengdu, SichuanAges 18–80 - NCT06871878Recruiting
Physiotherapy with telerehab after stroke
This trial tests a physiotherapy program that includes some sessions done at home using video calls. It aims to see if this extra therapy time can help improve arm and leg movement after a stroke.
BothwellAges 16 years+ - NCT06879444Enrolling by invitation
Core strength and pelvic floor in Sjogren's
This study looks at how core stability and pelvic floor muscles work in people with primary Sjogren's syndrome. If you have this condition, the results may help doctors understand changes in muscle function.
Denizli, DenizliAges 18–65 - NCT06875063RecruitingPhase 1
CAR-T cell therapy for CD19-positive relapsed B-cell lymphoma
This trial tests a new CAR-T cell therapy (a type of immune cell treatment) for patients with a specific kind of B-cell lymphoma that has come back or not responded to previous therapy. The treatment targets a protein called CD19 on the cancer cells to help your immune system fight the lymphoma.
Xiamen, FujianAges 18–70 - NCT06876532Recruiting
Inflammation score and Lu-177 treatment for midgut NET
This study looks at whether a simple blood test (inflammation score) can predict how well the drug Lu-177 oxodotreotide (Lutathera) will work for people with midgut neuroendocrine tumors that have grown or spread. It may help doctors understand who benefits most from this treatment.
AngersAges 18 years+ - NCT06877403Enrolling by invitation
Fatigue study in myasthenia gravis patients
This study looks at how common and how severe fatigue is in people with myasthenia gravis. It aims to understand the impact of fatigue on daily life and may help improve care for patients with this condition.
Clermont-FerrandAges 18 years+ - NCT06874894Enrolling by invitation
Blood Thinner Safety in Asians With Atrial Fibrillation
This study is looking at how blood thinners work in Asian people with atrial fibrillation. It aims to better understand the balance between preventing strokes and the risk of bleeding.
GwangmyeongAges 1.5 years+ - NCT06876064Recruiting
Tracking people at risk for rheumatoid arthritis
This study follows different groups of people—from those at high risk of developing rheumatoid arthritis to those recently diagnosed—to learn more about the disease. By joining, you help researchers understand who gets RA and why, which may lead to earlier detection and better care.
Montpellier, HéraultAges 18–80 - NCT06875401Enrolling by invitation
Long-term health after abdominal cerclage for preterm birth prevention
This study looks at how women who had an abdominal cerclage are doing in the long term. It aims to understand their health and well-being after this procedure to prevent early delivery.
Aarhus NAges 18 years+ - NCT06871228Recruiting
Stopping blood thinners after successful AF ablation with close heart monitoring
This trial tests whether people with atrial fibrillation who have had a successful ablation procedure can safely stop taking blood thinners (NOACs) if they wear a monitor to check for any silent heart rhythm problems. It may help you avoid the risks of long-term blood thinner use if your ablation has been effective.
Hefei, AnhuiAges 18–80 - NCT06868836RecruitingPhase 2
Study of a new antibody combination for advanced lung cancer after targeted therapy
This trial tests a new drug (JS207) that targets both PD-1 and VEGF pathways, given alone or with other treatments, for people with advanced non-small cell lung cancer that has a specific gene change and has stopped responding to targeted therapy (TKI). The goal is to see if this combination can help shrink tumors or slow cancer growth.
Guangzhou, GuangdongAges 18–75
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,207 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.